On-Demand Sessions

Course Directors: Vivek Kaul, MD, FACG, and Laura E. Raffals, MD, MS, FACG

Attend this year’s virtual Annual Postgraduate Course, “Best Evidence, Best Practice!” and gain practical takeaway points that you can implement in practice. Learn better ways to integrate the newest tools in diagnosis with the latest therapeutic/treatment alternatives to achieve optimal outcomes, improve your awareness and ability to incorporate patient care decision-making issues relating to common and not-so-common GI patient conditions, and enhance your overall capacity to frame effective disease management strategies in your practice.

NEW for ACG 2020! We have added an ACG All Access Pass, combine the three ACG Friday courses with the Postgraduate Course and the Annual Meeting plus the two bonus sessions (formerly the Learning Lunches and Breakfast Sessions) and save 20 percent! Register for any two courses and save up to 10 percent!

On-Demand Sessions
Session 1A: IBD: A Personalized Approach to a Complex Disease
Moderator: David A. Schwartz, MD, FACG
  • Pearls in IBD Management
    Laura E. Raffals, MD, MS, FACG
    Appreciate importance of early intervention treatment strategies, the role of therapeutic monitoring, and alternative causes of symptoms other than inflammation in the IBD patient.
  • Updates in the Treatment of Crohn’s Disease
    David A. Schwartz, MD, FACG
    Review current treatment strategies for moderate to severe Crohn’s disease.
  • Positioning Treatment in Ulcerative Colitis
    Marla C. Dubinsky, MD
    Discuss positioning of therapies to improve long-term outcomes in ulcerative colitis.
  • De-escalation of IBD Treatment: When Can We Back Off?
    David T. Rubin, MD, FACG
    Review evidence and strategies for de-escalation of therapy in IBD patients.
Session 1B: Esophagus
Moderator: Nicholas J. Shaheen, MD, MPH, FACG
  • Esophageal Dysmotility: Evaluation and Treatment
    John E. Pandolfino, MD, MSCI, FACG
    Discuss the differential diagnosis of esophageal dysmotility, approach to evaluation, and current management concepts.
  • Management of Esophageal Strictures
    Vani J.A. Konda, MD, FACG
    Outline the latest evidence-based recommendations for management of benign and malignant esophageal strictures.
  • Multimodal Management of BE Dysplasia/Neoplasia
    Nicholas J. Shaheen, MD, MPH, FACG
    Demonstrate the current state-of-the-art approach to endoscopic management of dysplastic Barrett’s esophagus and early esophageal neoplasia.
  • Eosinophilic Esophagitis Treatment Approaches in 2020
    Prasad G. Iyer, MD, FACG
    Analyze evidence-based approaches to the treatment of eosinophilic esophagitis including dietary modifications, medical therapy, and endoscopic esophageal dilation.
Session 1C: Endoscopy
Moderator: Navtej S. Buttar, MD
  • Risk Management, Quality, and Safety in the Endoscopy Unit
    Vivek Kaul, MD, FACG
    Identify the latest guideline and evidence-based recommendations as well as best practices to ensure quality and safety in the endoscopy unit and strategies to mitigate risk.
  • Evidence-Based Approach to Endosurgery: Does It Make the Cut?
    Navtej S. Buttar, MD
    For the general gastroenterologist, review appropriate utilization of endoscopic resection, techniques, and devices in various clinical scenarios based on best evidence and guidelines.
  • Interventional EUS: A Primer for the General Gastroenterologist
    Laith H. Jamil, MD, FACG
    Summarize the well-established and paradigm shifting interventional EUS procedures that the general gastroenterologist needs to be aware of, including limitations, risks, benefits, and alternatives.
Session 2A: Functional GI Disorders – Leveraging the Mind-Gut Connection
Moderator: Lin Chang, MD, FACG
  • Brain-Gut Axis and Its Interaction With the Enteric Microbiome
    Lin Chang, MD, FACG
    Explore the communication between the brain and the gut and role of the gut microbiome in functional GI disorders.
  • Positive Psychology Interventions for Functional GI Disorders
    Laurie A. Keefer, PhD
    Discuss opportunities for gastroenterologists to incorporate positive psychology interventions into their patient care strategies.
  • A Practical Approach to the Use of Anti-Depressants for Functional Disorders
    Brian E. Lacy, MD, PhD, FACG
    Review indications and use of anti-depressants for treatment of functional GI disorders.
  • Dietary and CAM Approaches for Management of IBS
    William D. Chey, MD, FACG
    Examine the latest evidence for use of diet and alternative medicines for IBS management.
Session 2B: Hepatology Issues in Everyday Practice
Moderator: Arun J. Sanyal, MD
  • Multidisciplinary Management of the NASH Patient
    Arun J. Sanyal, MD
    Describe the importance of a multidisciplinary management approach to the patient with obesity, including lifestyle, medical, endoscopic, and surgical management options.
  • Liver Disease in Pregnancy
    Nancy S. Reau, MD, FACG
    Review the approach to differential diagnosis and management of various types of clinically significant liver conditions that develop during pregnancy.
  • Drug-induced Liver Injury
    K. Gautham Reddy, MD, FACG
    Discuss the current concepts related to investigation and management of drug-induced liver diseases.
  • Viral Hepatitis Treatment Update
    Kimberly A. Brown, MD
    Summarize the recent advances in viral hepatitis treatment and discuss future trends in this realm, to include access to care, healthcare economics, and public health impact issues.
  • Evaluation of the Patient With a Liver Mass
    Stanley M. Cohen, MD, FACG
    Discuss principles, strategies, and best practice approaches for evaluating liver masses based on differential diagnosis.
Session 2C: All Things Colon!
Moderator: Mark B. Pochapin, MD, FACG
  • Colorectal Cancer Screening and Surveillance - Incorporating Guidelines Into Practice
    Mark B. Pochapin, MD, FACG
    Summarize colorectal cancer screening guidelines and identify the role of noninvasive screening methods.
  • Management of Lower GI Bleeding
    John R. Saltzman, MD, FACG
    Review diagnostic and therapeutic options for management of diverticular bleeding.
  • Hereditary Colorectal Polyposis and Cancer Syndromes
    Carol A. Burke, MD, FACG
    Review diagnosis and management of hereditary colon cancer syndromes.
Symposium A: Practical Tips and Pearls in IBD Management
Moderator: Christina Y. Ha, MD, FACG
  • Managing the Hospitalized IBD Patient
    Christina Y. Ha, MD, FACG
    Discuss therapeutic approaches to the hospitalized IBD patient including importance of nutrition, VTE prophylaxis, and pain management.
  • IBD Surveillance, Chromoendoscopy, and Future Directions
    Samir A. Shah, MD, FACG
    Review appropriate surveillance strategies and role of chromoendoscopy in practice and discuss proper methods for performing chromoendoscopy.
  • Preventive Care in IBD
    Millie D. Long, MD, MPH, FACG
    Discuss best practice recommendations for optimal preventive care in the IBD patient.
Symposium B: Pancreaticobiliary Disease: Recent Advances
Moderator: Timothy B. Gardner, MD, MS, FACG
  • Acute Pancreatitis: Why Are Patients Still Dying?
    Timothy B. Gardner, MD, MS, FACG
    Discuss the importance of goal-directed fluid therapy and multidisciplinary medical management in patients with severe acute pancreatitis to ensure good outcomes.
  • Screening for Sporadic Pancreatic Cancer: An Update
    Suresh T. Chari, MD, FACG
    Discuss recent advances and data in pancreas cancer screening.
  • Evaluation/Management of the Indeterminate Biliary Stricture
    Prabhleen Chahal, MD, FACG
    Review best practice approaches to the evaluation and management of indeterminate biliary strictures.
Symposium C: Obesity
Moderator: Allison Schulman, MD, MPH
  • Bariatric Endoscopy: An Inflated Sense of Success?
    Allison Schulman, MD, MPH
    Interpret the evidence-based literature supporting the role of endoscopic interventions in patients with obesity.
  • Bariatric Surgery: Cannot Bypass the Surgeon!
    John M. Morton, MD, MPH, MHA, FACS
    Compare surgical options for optimal outcomes in patients with obesity.
  • Medical and Behavioral Management of Patients with Obesity: The Foundation for Long-Term Success
    Shelby A. Sullivan, MD, FACG
    Recognize the importance of lifestyle, nutrition, and behavioral interventions as part of the comprehensive approach to obesity management.
Symposium D: A Practical Approach to Anorectal Disorders
Moderator: Satish S.C. Rao, MD, PhD, FACG
  • The Role of Pelvic Floor Retraining for Dyssynergic Defecation
    Satish S.C. Rao, MD, PhD, FACG
    Outline treatment approaches for dyssynergic defecation disorders.
  • Modern Approaches to Fecal Incontinence
    Stacy B. Menees, MD, MS
    Appraise available therapies for fecal incontinence.
  • Anorectal Manometry Testing: A Primer for the General Gastroenterologist
    Darren M. Brenner, MD
    Review anorectal manometry testing and its role in clinical practice.
Symposium E: Endoscopy
Moderator: Michael B. Wallace, MD, MPH, FACG
  • All the Endoscopy vs Surgery RCTs I Could Come Up With!
    Michael B. Wallace, MD, MPH, FACG
    Discuss recent landmark RCTs that have resulted in a huge impact on GI medical-surgical practice.
  • GI Emergencies: How to Optimize Outcomes in Dire Circumstances
    John R. Saltzman, MD, FACG
    Apply strategies to achieve the best outcomes in patients presenting with acute GI emergencies.
  • Endoscopy in Special Populations
    Douglas G. Adler, MD, FACG
    Evaluate the approach to endoscopy in unique patient populations (pediatrics, geriatrics, pregnancy, etc.) with higher risk and special needs or challenges.
Symposium F: Autoimmune and Cholestatic Liver Disease
Moderator: Paul Y. Kwo, MD, FACG
  • Predictors of Disease Course in Primary Sclerosing Cholangitis
    Kris V. Kowdley, MD, FACG
    Review the clinical course of primary sclerosing cholangitis and predictors of disease progression and complications.
  • Advances in Primary Biliary Cholangitis Treatment
    David E. Bernstein, MD, FACG
    Discuss precision treatment of primary biliary cholangitis.
  • Autoimmune Hepatitis
    Paul Y. Kwo, MD, FACG
    Describe the clinical management of patients with autoimmune hepatitis.